Ian Chiang

Ian is a Partner at Flare Capital and led the firm’s investments in Atlas Oncology Partners, Isaac Health, Keebler Health, Knownwell, Peer AI, Rx Redefined, and Qualified Health.

He was also a core investment team member in the firm’s investments in Nadia Health, Inbound Health, Oshi Health, and RightMove, where he serves as a Board member. Additionally, Ian led the firm’s Flare Scholar Ventures investments in Adni, Sprouts Labs, Qualified Health AI, and Vincere Health (acquired by RVO Health).

Prior to joining Flare Capital, Ian served as a Senior Vice President and a founding member of CareAllies, Cigna’s family of multi-payer provider services, population health management, and home-based care businesses. The Cigna Group Completes Sale of Medicare and CareAllies Businesses to HCSC in 2025 for $3.3 billion. In that capacity, he was responsible for developing new technology-enabled services, evolving existing solutions and service lines, and providing ongoing product management across CareAllies’ businesses. In addition, he was also responsible for developing inorganic strategies for CareAllies since its inception. Before launching CareAllies, Ian held a leadership position with Cigna’s US Strategic Operations team.

Ian was a co-founder of several start-ups, including XcelDx, which ultimately became Scanwell Health, a smartphone-enabled diagnostics company backed by Y-Combinator, Founders Fund, DCM, Version One, and Mayfield. He focused his efforts on product development and served as an advisor to the company. Scanwell was acquired by BD (Becton, Dickinson and Company) in 2021. He also worked for Becton, Dickinson & Company, where he led new product innovation and development. He continues to actively advise and mentor a number of innovative healthcare start-ups. He started his career at McKinsey & Company and spent five years advising healthcare clients globally.

Ian serves as an advisor and board member of various organizations. He is currently a member of the Board of Directors at The New England Venture Capital Association and Harvard Business School Healthcare Alumni Association, where he also served as the 2021 Annual Conference Co-Chair. Additionally, Ian serves as an Industry Advisor at Cornell Tech’s Precision Behavioral Health Initiative and a member of the Health Tech Advisory Committee of the Jacobs Technion–Cornell Institute at Cornell Tech. He also co-founded the Cornell Tech’s Health Tech Summit and has served as a conference co-chair and organizer since its inception. Ian has a Bachelor of Science degree in biological engineering from Cornell University, where he graduated with honors and was a Cornell Presidential Research Scholar. He also holds an MBA from Harvard Business School.